Clinical efficacy of Fufang Yangxue Tang for cancer-related anemia

VernacularTitle:复方养血汤治疗癌性贫血的临床疗效观察
Author: Wenlei HU ¹ ; Yuzhou HE
Author Information

1. 浙江省乐清市人民医院中西医结合科
Keywords: Fufang Yangxue Tang; Cancer-related anemia; EPO
From: China Modern Doctor 2015;(11):128-131
CountryChina
Language:Chinese
Abstract: Objective To discuss clinical efficacy of Fufang Yangxue Tang for cancer-related anemia. Methods Clini-cal data of 120 cases with cancer-related anemia were respectively analyzed. 64 cases of control group were treated by EPO, and 56 cases of study group were treated by Fufang Yangxue Tang based on treatment of EPO. Clinical efficacy of two groups was compared. Results After treatment of 8 weeks, efficiency of study group was 67.9%, and performance status improvement rate was 82.1%, which were higher than control group (P<0.05);Hb and Hct levels after treatment of 4 weeks and 8 weeks increased compared with before treatment(P<0.01), and study group improved more(P<0.01). Conclusion Fufang Yangxue Tang combined with EPO in treatment of cancer-related anemia can improve clinical effi-cacy, improve performance status and Hb and Hct, worthy of clinical promotion.